INIS
patients
100%
radiotherapy
70%
cancer
57%
carcinomas
53%
doses
36%
combined therapy
33%
risks
28%
toxicity
28%
diseases
24%
chemotherapy
21%
organs
20%
esophagus
11%
adenocarcinomas
11%
oral cavity
11%
secretion
10%
myeloid leukemia
10%
glands
10%
hematopoiesis
10%
lymphomas
10%
spleen
10%
trachea
10%
stratification
10%
antidiuretic hormone
10%
precursor
10%
viruses
10%
therapy
10%
detection
10%
inventories
10%
humans
10%
hydroxyurea
10%
metastases
9%
volume
8%
radiations
7%
growth
7%
quality of life
7%
necrosis
6%
malignancies
6%
tumors
5%
larynx
5%
comparative evaluations
5%
planning
5%
adrenal glands
5%
Medicine and Dentistry
Patient
67%
Head and Neck Cancer
41%
Therapeutic Procedure
38%
Experience
31%
Intensity Modulated Radiation Therapy
24%
Analysis
23%
Squamous Cell Carcinoma
23%
Radiation Therapy
21%
Chemoradiotherapy
14%
Toxicity
14%
Inpatient
13%
Tertiary Care
12%
Hydroxyurea
11%
Esophagus
11%
Radiation
11%
Head and Neck Squamous Cell Carcinoma
11%
Diagnostics
10%
Spinal Cord Compression
10%
Extramedullary Hematopoiesis
10%
Thalassemia Intermedia
10%
Chemotherapy Regimens
10%
Photophobia
10%
Medical Oncology
10%
Oral Cavity
10%
Cerebrospinal Fluid Rhinorrhea
10%
Swallowing
10%
Precursor
10%
CHOP
10%
Lymphoma
10%
Chronic Myelogenous Leukemia
10%
Syndrome
10%
Aptitude
10%
Parotid Gland
10%
Cholesteatoma
10%
Wart Virus
10%
Brachial Plexus
10%
Ichthyosis
10%
Dihydrotachysterol
10%
Organ
10%
Alopecia Mucinosa
10%
Plummer-Vinson Syndrome
10%
Syndrome of Inappropriate Antidiuretic Hormone Secretion
10%
Follow up
9%
Growth
8%
Disease
7%
Adrenal Gland
6%
Chemotherapy
6%
Non-Hodgkin Lymphoma
6%
Lesion
6%
Quality of Life
5%
